Only few studies in selected cohorts have examined whether the CHA2DS2‐VASc score can predict the risk of atrial fibrillation and thromboembolic events in patients without atrial fibrillation. Click to show full abstract
Only few studies in selected cohorts have examined whether the CHA2DS2‐VASc score can predict the risk of atrial fibrillation and thromboembolic events in patients without atrial fibrillation.
               
Click one of the above tabs to view related content.